Verily drew widespread praise last year when it announced an “ambitious endeavor” to combat the opioid epidemic: an addiction medicine campus in Ohio called OneFifteen, its name a nod to the 115 people who died each day in 2017 of opioid overdoses.
But in the year and a half since OneFifteen’s high-profile launch, Verily has remained relatively quiet about its progress — and its role in the effort, which is a collaboration between the Alphabet life science subsidiary and two local health systems.
Verily and its partners set out to create a “learning health system” — and in the past 18 months, that system has started to take shape. OneFifteen has opened two of four planned facilities: an outpatient clinic where patients can receive medication-assisted treatment and a crisis-stabilization unit that functions as an alternative to the emergency room for patients still under the influence or experiencing active withdrawal from opioids. OneFifteen plans to open the remaining two facilities, both live-in residences, in the fall of 2020.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect